Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 3362 of 6351
-
Mayo clinic tests which brain stimulation frequency stops seizures best
Knowledge-focused Recruiting nowA primary purpose of this study is to better understand what stimulation parameters work best for patients. For example, for Deep Brain Stimulation (DBS) of the Anterior Nucleus of the Thalamus (ANT), it is not clear what stimulation frequency leads is most effective. This study …
Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:54 UTC
-
Brain secrets of weight-loss surgery revealed
Knowledge-focused CompletedThe goal of this project is to understand why bariatric surgery is such an effective treatment for obesity with a focus on brain mechanisms. Cerebrospinal fluid (CSF) neuropeptide, hormone and protein levels will be measured as a surrogate for changes in brain activity in partici…
Sponsor: Columbia University • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:00 UTC
-
Personalized tamoxifen dosing: can a PET scan show the way?
Knowledge-focused Recruiting nowDespite broad advancements in endocrine therapy for ERα+ breast cancer, resistance ultimately develops. A common driver of resistance are known ESR1 mutations that lead to constitutively active receptor signaling and transcriptional regulation that is always "turned on" despite t…
Early phase 1 • Sponsor: University of Wisconsin, Madison • Aim: Knowledge-focused
Last updated Jul 23, 2026 00:00 UTC
-
Cancer drug darolutamide gets extended safety check in ongoing study
Disease control OngoingThe aim of this study is to provide darolutamide treatment to patients who participated in a previous study with darolutamide supported by Bayer and the treating doctor considers that the continuation of the treatment with darolutamide to be beneficial. Patients will be carried o…
Phase 3 • Sponsor: Bayer • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC
-
Free HPV shots help prevent cancer in Low-Income adults
Vaccine CompletedThis phase IV trial examines the impact of an education program on the human papilloma virus (HPV) and its effects on the acceptance and completion rates of a free HPV vaccination program in underserved adult patients. Participating in the HPV educational program may increase the…
Phase 4 • Sponsor: Mayo Clinic • Aim: Vaccine
Last updated Jun 27, 2026 08:10 UTC
-
Spit test could make COVID-19 screening easier
Diagnosis CompletedThe investigators hypothesize that detection of SARS-CoV2 on saliva samples will increase the performance of the screening program compared to the reference strategy (RT-PCR on a nasopharyngeal swab).
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Diagnosis
Last updated Jun 27, 2026 11:00 UTC
-
New study tests Chat-Based tool to cut opioid use after surgery
Symptom relief CompletedThe purpose of this study is to test the impact of a bundled NOHARM Conversation Guide with clinical decision support intervention embedded within an Electronic Health Record (EHR) on pain and function 3 months following surgery.
Sponsor: Mayo Clinic • Aim: Symptom relief
Last updated Jun 27, 2026 07:57 UTC
-
Smart dosing keeps chemo on track for GI cancer patients
Disease control CompletedThe study is testing an intervention of an investigator-developed chemotherapy dose adjustment algorithm. The primary objective of this study is to evaluate the effectiveness of the chemotherapy dose adjustment algorithm for reducing unplanned delays in patients receiving FOLFOX …
Sponsor: Dartmouth-Hitchcock Medical Center • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC
-
Can extra Check-Ups after stroke or heart attack save lives and money?
Disease control CompletedCerebral Vascular Accidents (stroke) and Myocardial Infarction (MI), which share the same risk factors, treatments and pathophysiological mechanisms, have become two major public health problems due to the increase in their prevalence rate and the longer survival after such an ev…
Sponsor: Centre Hospitalier Universitaire Dijon • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC
-
New combo therapy aims to outsmart hard-to-treat breast cancer
Disease control Recruiting nowThe hypothesis of this pilot trial is that administration of bortezomib will inhibit NHEJ in metastatic TNBC leading at the time of disease progression to metastases that are HR-deficient and sensitive to pembrolizumab and cisplatin therapy. The trial will include in depth analys…
Early phase 1 • Sponsor: Baylor Research Institute • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC
-
App aims to ease perinatal depression in thousands of women
Symptom relief CompletedThe purpose of this research study is to find out about ways to enhance well-being during pregnancy and the postpartum period (after the baby is born). The "Mamma Mia" program and/or guided support from study staff ("Mamma Mia Plus") may be helpful because the app provides skills…
Sponsor: Virginia Commonwealth University • Aim: Symptom relief
Last updated Jul 04, 2026 00:00 UTC
-
Your phone could help beat depression: new app trial launches
Symptom relief Recruiting nowTesting and validating an e-health (smartphone application) approach to better understand the determinants of day-to-day symptomatology in depression, medication adherence, and treatment efficacy in the goal of maximizing patient care.
Sponsor: Centre Hospitalier Charles Perrens, Bordeaux • Aim: Symptom relief
Last updated Jun 27, 2026 11:01 UTC
-
Heart surgery bowel breakthrough? drug may speed recovery
Symptom relief CompletedPostoperative ileus, defined as the transient postoperative functional inhibition of propulsive bowel activity, commonly occurs in patients after cardiac surgery and contributes to postoperative morbidity. Naloxegol is a peripheral opioid receptor antagonist. Recent studies show…
Phase 3 • Sponsor: CMC Ambroise Paré • Aim: Symptom relief
Last updated Jun 27, 2026 12:36 UTC
-
Soft cast could ease healing of diabetic foot sores
Disease control Recruiting nowTo determine the effectiveness, compliance, patient tolerance, ease of use and safety of total contact soft cast in diabetic foot ulcers.
Sponsor: University of Minnesota • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC
-
New antibody shows promise for blistering skin disease
Disease control CompletedThe development of Auto Immune bullous Diseases (AIBD) results from a complex interaction between innate and adaptive immune systems. Bullous pemphigoid (BP), the most frequently encountered AIBD, predominantly affects elderly patients above 70 with an estimated incidence of 21.7…
Phase 2 • Sponsor: Centre Hospitalier Universitaire de Nice • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
Bone drug breakthrough: could less be more for cancer patients?
Symptom relief OngoingThe investigators propose to perform a pragmatic, multicenter, open-label, randomised clinical trial to demonstrate the efficacy and safety of either continuing or further de-escalating BMA after a minimum of two years of BMA treatment in patients with bone metastases from breast…
Phase 4 • Sponsor: Ottawa Hospital Research Institute • Aim: Symptom relief
Last updated Jul 23, 2026 00:00 UTC
-
New hope for Hard-to-Treat cancers?
Disease control OngoingThe purpose of this study is to assess the safety and tolerability of DS-1055a in participants with relapsed or refractory locally advanced or metastatic solid tumors for which no standard treatment is available.
Phase 1 • Sponsor: Daiichi Sankyo • Aim: Disease control
Last updated Jun 27, 2026 11:04 UTC
-
Exercise tailored to boost heart health in breast cancer survivors
Symptom relief Recruiting nowThis study will compare the effects on cardiorespiratory fitness (CRF) of aerobic exercise in different amounts (number of minutes/session) over different periods of time (number of weeks). Aerobic exercise is physical activity of light-to-moderate intensity that uses the large m…
Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Symptom relief
Last updated Aug 28, 2026 00:00 UTC
-
Lung cancer maintenance combo trial stopped early
Disease control Stopped earlyThe purpose of the study is to determine whether adding vorolanib to atezolizumab will improve the length of time that participants are cancer-free after receiving standard chemotherapy.
Phase 2 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC
-
Canadian study checks how well RA drug works in daily life
Disease control CompletedRheumatoid Arthritis (RA) is an inflammatory disease of the joints causing pain, stiffness, swelling and loss of joint function. This study will assess how effective Upadacitinib is in changing the disease symptoms in Canadian participants with RA. Upadacitinib is a drug approve…
Sponsor: AbbVie • Aim: Disease control
Last updated Jun 26, 2026 12:41 UTC